Keywords: bayer, extends, support, hemophilia, prophylaxis, study, biological

Bayer extends support for hemophilia prophylaxis study

Article | 19 July 2004

Print This

Bayer Biological Products, a US unit of Germany's Bayer, is extendingits support for a landmark study evaluating the treatment differences ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in